News
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
Mainz Biomed N.V. to attend the 38th GARPS Annual Meeting in Germany to showcase its cancer detection solutions and strengthen partnerships with key opinion leaders in gastroenterology -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
Mainz Biomed reports positive topline results from feasibility study of biomarker panel for pancreatic cancer detection, achieving 100% sensitivity and 95% specificity. The study paves the way for a reliable, non-invasive screening test -
-